Mode
Text Size
Log in / Sign up
N/A Completed N=136 Randomized Quadruple-blind Supportive Care

Auriculotherapy During Medication Abortion

Abortion Early
Source: ClinicalTrials.gov NCT03900728 ↗
Enrolled (actual)
136
Serious AEs
0.0%
Results posted
Apr 2021
Primary outcomePrimary: Pain VAS Score — 75; 60; 55 score on a scale

Summary

This randomized trial will evaluate the effect of adding auriculotherapy (i.e. acupuncture applied to the ear) using either gold beads or Pyonex needles in addition to usual care for the relief of pain and anxiety during medication abortion. The control group will receive placebo auriculotherapy plus usual care. Participants will receive the assigned treatment immediately after they receive their initial abortion medication. The investigators will assess pain and anxiety via text message once daily for four days, and in person at a one-week follow-up visit.

Outcome Measures

OutcomeResultp-value
PRIMARY
Pain VAS Score
75; 60; 55
SECONDARY
Anxiety VAS Score
45; 10; 30

Eligibility Criteria

Inclusion Criteria

  • Pregnant up to 10 weeks (70 days) gestation
  • Seeking medication abortion with mifepristone and misoprostol
  • Initial clinical care completed and mifepristone administered
  • English- or Spanish-speaking
  • Able to use a mobile phone for follow-up on days 1-4

Exclusion Criteria

  • Not a candidate for medication abortion for any reason
  • Allergy to adhesives
View full record on ClinicalTrials.gov →

Data sourced from ClinicalTrials.gov (NCT03900728). Outcome figures and adverse-event rates are extracted automatically from the registry's posted results and are provided for clinician reference, not as a substitute for the primary publication. Informational only — not medical advice.

Back to search